Srinivas Sadu ’97 was re-appointed as the CEO and managing director of Gland Pharma Limited, a small-molecule generic injectables-focused company. Under Sadu’s leadership since 2019, Gland Pharma has consistently witnessed growth in terms of revenue and profits while expanding across the globe by entering new strategic markets.
